nickel bis(sulfamidate) (CAS 13770-89-3) — Safety Data Sheet
Safety data sheet documentation for nickel bis(sulfamidate) (CAS 13770-89-3), compiled to REACH Annex II with classification read against the harmonised entry in CLP Annex VI (H350i, H341, H360D, H302). Two options: a working draft sent by e-mail immediately, or a signed card issued within 72 hours of complete input. The item supplied is a document — MolGod.org does not sell, supply or ship chemical substances.
Issued to order — reviewed and signed within 72 hours of complete input. This substance carries a harmonised classification we do not issue automatically. The document is read section by section by a reviewer before it leaves us, so the immediate download is not offered here.
We are not issuing this sheet yet.
Our engine could not build a document for this substance that meets our own completeness threshold, so it is held for review rather than published. We would rather tell you that than sell you a sheet we do not stand behind.
Leave your details and we will tell you when it is ready, or what we can issue in the meantime.
Identity, structure, physical and chemical properties, analytical data and the literature — every value with the source it came from and the date that source was read. The full record is in the data sections further down this page.
Identity CAS · EC · IUPAC · synonyms · molecular formula · molecular weight
Structure 2D · 3D · SMILES · InChI · InChIKey
Physical melting point · boiling point · density · vapour pressure · solubility
Chemical reactivity · stability · incompatible materials
Analytical spectra and methods where available
References literature, with DOI where a DOI exists
Identifier coverage is shown as a count, not as a quality rating. It tells you how well characterised this substance is in public data — which is a different question from how good it is, and a more useful one when you are deciding whether the documentation behind it can be defended.
This page sells the documentation for this substance, not the substance. Choose the level you need.
€0Audit the sheet you already haveSend us your existing sheet for this substance and we tell you what is wrong with it. One per company. If it turns out to be sound, you buy nothing.Start the free audit →
€49.99Working draftThe complete sixteen-section document, referenced, downloadable immediately after checkout. The right choice while the paperwork is still moving.
€249.99Signed cardThe same document reviewed and signed, issued within 72 hours of complete input — for the moment somebody official asks who stands behind it.
Documentation available for this substance: safety data sheet · CLP label · certificate of analysis on request · specification. Languages: the official language of your destination market, produced per card.
Grade, purity, physical form, packaging, minimum order and lead time are not shown, because MolGod does not supply the material — those are facts about a seller, and there is no seller on this page. They appear on storefronts we build for suppliers, where somebody can answer for them.
What a compliance officer checks, and where it sits in the document. The values themselves are in the regulatory sections further down.
Classification harmonised entry with index number where one exists; self-classification shown separately and labelled, never merged
Hazard statements the official text, in the page language
Precautionary statements combined statements reproduced whole, never split
Pictograms and signal word
Inventory status per jurisdiction, each stated individually
Restrictions entry and scope where one applies
Authorisation entry and sunset date where one applies
Candidate list status and the supply-chain duty it triggers
Transport entry per mode — road, sea, air
Exposure limits per country, each naming the act it comes from
Document status revision date and the amendment in force when issued
Fields with no established status say so. This page never states that no restrictions apply — absence from a dataset is not clearance, and a document that treats it as clearance is the most dangerous kind of document in this field.
A digital PDF safety data sheet in the sixteen-section structure of REACH Annex II (Regulation 1907/2006).
Substance identification, hazard classification, physicochemical, toxicological and ecological information, and regulatory references.
Classification read against the harmonised entry in CLP Annex VI where one exists for the substance.
A version number, a compilation date, and the source behind each value that carries one.
Delivery by e-mail. Nothing is shipped.
What this is not
Not a chemical substance, not a sample, not any physical goods.
Not a certification. No official certification scheme for safety data sheets exists in the European Union.
Not legal approval, and not a guarantee of compliance in any jurisdiction.
Not a substitute for your own regulatory assessment, nor for the safety data sheet supplied by the manufacturer or importer of the substance you actually hold.
Not adapted to a specific workplace, process or national annex unless you provide that information.
Where the available evidence does not support a value, the sheet states that the value is not established rather than estimating one. A field with no recorded source is marked as such.
What is in the buyer pack
Everything your compliance officer will ask for, in one file.
The product page as PDF — the record as published, so what you forward matches what you read.
The safety data sheet at your entitlement level — sixteen sections in the order set by REACH Annex II, for this substance, in the language you select.
The CLP label artwork — generated from the same classification as the sheet, so the two cannot disagree.
The specification, and the certificate of analysis where batch data exists.
sources.txt — every citation with the date it was read.
An explicit list of what we could not establish — fields marked unavailable rather than filled with an estimate. This is the honest part of the document and we do not hide it in a footnote.
Your European buyer is going to forward this to somebody who was not on the call. The pack exists so that what they forward is complete, self-explanatory and traceable — rather than four attachments and a sentence beginning “I think this is everything”.
These switch the language of this page. Single substances. Mixtures on enquiry. One document, one language — additional languages are priced separately. Every version, including the Chinese one, is written to EU law — (EC) No 1907/2006 (REACH) Annex II and (EU) 2020/878 — and translated from it. The Chinese version is a reference translation, not a legally valid document for the Chinese market: an SDS for China must be compiled separately to GB/T 16483 and GB/T 17519.
3D model Nickel sulfamate, CAS 13770-89-3, molecular formula H₄N₂NiO₆S₂, molar mass 250.87 g/mol
Data transcribed from regulatory registers and technical literature, with the source and edition stated. It does not replace the supplier's safety data sheet. Fields without a recorded source are marked as such.
PubChem. National Center for Biotechnology Information (NIH/NLM), chemical compound database. ↗
applies to: Molecular formula · Molecular weight · IUPAC name · SMILES · InChIKey
Bartolomeu Halicki PC, Kim JH, Griffin AF et al.. (2025). "Targeting Mycolic Acid Biosynthesis with Cyclic Sulfamates: A New Strategy against Mycobacterium tuberculosis.". ACS infectious diseases. htt
Sanematsu K, Nagasato Y, Lee Y et al.. (2025). "A single amino acid substitution in TAS1R2 defines species-specific sweet sensitivity to sulfamates in humans and mice.". Food chemistry. https://doi.or
Mustafa EM, Shahin AI, Alrashed AS et al.. (2024). "An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020-2024).". Archiv der Pharmazie. https://doi.org/10.1002/ard
Hosang L, Löhndorf A, Dohle W et al.. (2023). "2-Methoxyestradiol-3,17-O,O-bis-sulfamate inhibits store-operated Ca(2+) entry in T lymphocytes and prevents experimental autoimmune encephalomyelitis.".
Sundararaman SA, Odom John AR. (2022). "Adenosine sulfamates: Next generation of antimalarials.". Cell host & microbe. https://doi.org/10.1016/j.chom.2022.07.007
Chang CN, Lin IC, Lin TS et al.. (2022). "The Design, Structure-Activity, and kinetic studies of 3-Benzyl-5-oxa-1,2,3,4-Tetrahydro-2H-chromeno-(3,4-c)pyridin-8-yl sulfamates as Steroid sulfatase inhib
Awakawa T, Barra L, Abe I. (2021). "Biosynthesis of sulfonamide and sulfamate antibiotics in actinomycete.". Journal of industrial microbiology & biotechnology. https://doi.org/10.1093/jimb/kuab001
MOLECULE
Per-CAS bibliography (live from 13+ databases)
Sources: db:pubmed (11) · db:crossref (1)
db:pubmed
Bartolomeu Halicki PC, Kim JH, Griffin AF et al.. (2025). "Targeting Mycolic Acid Biosynthesis with Cyclic Sulfamates: A New Strategy against Mycobacterium tuberculosis.". ACS infectious diseases. https://doi.org/10.1021/acsinfecdis.5c00419 →
db:pubmed
Sanematsu K, Nagasato Y, Lee Y et al.. (2025). "A single amino acid substitution in TAS1R2 defines species-specific sweet sensitivity to sulfamates in humans and mice.". Food chemistry. https://doi.org/10.1016/j.foodchem.2025.145563 →
db:pubmed
Mustafa EM, Shahin AI, Alrashed AS et al.. (2024). "An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020-2024).". Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400331 →
db:pubmed
Siddiqui R, El-Gamal MI, Sajeev S et al.. (2023). "Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives.". Molecular and biochemical parasitology. https://doi.org/10.1016/j.molbiopara.2023.111582 →
db:pubmed
Hosang L, Löhndorf A, Dohle W et al.. (2023). "2-Methoxyestradiol-3,17-O,O-bis-sulfamate inhibits store-operated Ca(2+) entry in T lymphocytes and prevents experimental autoimmune encephalomyelitis.". Biochimica et biophysica acta. Molecular cell research. https://doi.org/10.1016/j.bbamcr.2023.119485 →
db:pubmed
Sundararaman SA, Odom John AR. (2022). "Adenosine sulfamates: Next generation of antimalarials.". Cell host & microbe. https://doi.org/10.1016/j.chom.2022.07.007 →
db:pubmed
Chang CN, Lin IC, Lin TS et al.. (2022). "The Design, Structure-Activity, and kinetic studies of 3-Benzyl-5-oxa-1,2,3,4-Tetrahydro-2H-chromeno-(3,4-c)pyridin-8-yl sulfamates as Steroid sulfatase inhibitors.". Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2022.106148 →
db:pubmed
Awakawa T, Barra L, Abe I. (2021). "Biosynthesis of sulfonamide and sulfamate antibiotics in actinomycete.". Journal of industrial microbiology & biotechnology. https://doi.org/10.1093/jimb/kuab001 →
db:pubmed
Mazo N, Navo CD, Peregrina JM et al.. (2020). "Selective modification of sulfamidate-containing peptides.". Organic & biomolecular chemistry. https://doi.org/10.1039/d0ob01061h →
db:pubmed
Potter BVL. (2018). "SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects.". Journal of molecular endocrinology. https://doi.org/10.1530/JME-18-0045 →
db:pubmed
Winum JY, Scozzafava A, Montero JL et al.. (2005). "Sulfamates and their therapeutic potential.". Medicinal research reviews. https://doi.org/10.1002/med.20021 →
db:crossref
(2004). "Nickel (
II
) Sulfamate 13770‐89‐3". Sax's Dangerous Properties of Industrial Materials. https://doi.org/10.1002/0471701343.sdp18463 →
Regulatory status of the substance
This substance is subject to regulatory requirements: hazardous waste management (BDO — national rule, Poland). Details in the \"Regulatory Status (REACH/ECHA/CLP)\" section and on the SDS. Regulatory information — does not restrict purchase in this store.
🧮 Stoichiometry Calculator
🧪 Chemical Data
CAS Number
13770-89-3
Molecular formula
H₄N₂NiO₆S₂
Molar mass
250.87 g/mol
IUPAC name (EN)
nickel(2+) disulfamate
SMILES
NS(=O)(=O)[O-].NS(=O)(=O)[O-].[Ni+2]
InChIKey
KERTUBUCQCSNJU-UHFFFAOYSA-L
📚 Related literature (5 articles)
Matched automatically from public bibliographic databases by text similarity. Not curated for this substance, and not part of the safety data sheet.
Spectra are fetched on demand from 9 sources. Each spectrum is stored in our database — the next time it is opened there are zero requests to the external API. Download JCAMP-DX / CSV / PNG for every spectrum without searching.
Type of data: Predicted (calculated by nmrshiftdb2, not measured) — inferred: the source file carries no deposited measurement Basis: the file returned by the NMRShiftDB search-or-predict service is a JCAMP-DX LINK block with spectrometer frequency 0, and its values match no deposited NMRShiftDB spectrum of this compound on record at MolGod.
⏳ Loading…
▶ Click to load spectrum
🔗 Source
About the downloads (Type of data: Predicted (calculated by nmrshiftdb2, not measured) — inferred: the source file carries no deposited measurement) JCAMP: the NMRShiftDB file as received (JCAMP-DX 5.01 text). It is a peak list: chemical shift in ppm. MolGod adds header lines stating the type of data; the values are unchanged. CSV: the same peak list in two columns. The second column repeats the shift value; it is not a signal intensity. Lines starting with # state the type of data. PNG: a picture of the plot above, with the type of data written on it. Use: where signals are expected or were reported (chemical shift positions). Not included or guaranteed: intensities, multiplicities, coupling constants, line shapes, and solvent or temperature unless stated. A predicted list is not a measurement and cannot serve as a reference spectrum for identity or purity testing. Downloads become active after Show.
Data is fetched once (JCAMP-DX parser) and stored in the plugin's local database. No duplicate downloads, no NIST queries on subsequent openings. Licences respected (only a deep link plus our own visualisation is published).
Data retrieved live from multiple sources (priority chain). JCAMP-DX / CSV / PNG available for download under each spectrum.
IR — Fourier-transform infrared
Loading IR — Fourier-transform infrared…
MS — Mass spectrometry (EI 70eV)
Loading MS — Mass spectrometry (EI 70eV)…
NMR spectrum — not applicable (inorganic compound)
For CAS 13770-89-3, the structure contains no carbon atoms or C–H bonds. 1H/13C NMR spectroscopy applies to organic compounds — for an inorganic substance (salt, mineral acid), predicting 1H/13C shifts is not applicable.
🔎 Spectrum Search (JCAMP-DX)
Upload a JCAMP-DX file (.jdx, .dx, .jcm) — the system will calculate the cosine similarity against all spectra in the database and display the TOP 10 matches.
📚 Bibliography (Chicago)
McLafferty, Fred W., ed. 2018. Wiley Registry of Mass Spectral Data. 11th ed. Hoboken, NJ: Wiley. A reference MS library (~775k spectra).
Stein, Stephen E., and Donald R. Scott. 1994. "Optimization and Testing of Mass Spectral Library Search Algorithms for Compound Identification." Journal of the American Society for Mass Spectrometry 5 (9): 859–866. The cosine + dot-product algorithm of NIST MS Search.
McDonald, Robert S., and Paul A. Wilks Jr. 1988. "JCAMP-DX: A Standard Form for Exchange of Infrared Spectra in Computer Readable Form." Applied Spectroscopy 42 (1): 151–162. The JCAMP-DX specification (extended to 5.01 for NMR/MS).
McLafferty, Fred W., and František Tureček. 1993. "Interpretation of Mass Spectra." 4th ed. Mill Valley, CA: University Science Books. Cosine-similarity matching and MS fragmentation — the foundation of the search algorithm.
Sumner, Lloyd W., Alexander Amberg, Dave Barrett, Michael H. Beale, Richard Beger, Clare A. Daykin, Teresa W.-M. Fan, et al. 2007. "Proposed Minimum Reporting Standards for Chemical Analysis." Metabolomics 3 (3): 211–221. MSI Level 1-4 — confidence-level standards for spectral matching.
Stein, Stephen E. 1999. "An Integrated Method for Spectrum Extraction and Compound Identification from Gas Chromatography/Mass Spectrometry Data." Journal of the American Society for Mass Spectrometry 10 (8): 770–781. The AMDIS algorithm — deconvolution + library match (NIST).
Lindon, John C., George E. Tranter, and David W. Koppenaal, eds. 2017. "Encyclopedia of Spectroscopy and Spectrometry." 3rd ed. Amsterdam: Academic Press. Encyclopedia entries on spectral library searching.
Smith, Brian C. 2011. "Fundamentals of Fourier Transform Infrared Spectroscopy." 2nd ed. Boca Raton, FL: CRC Press. FT-IR and the JCAMP-DX format for transmission spectra.
Larkin, Peter. 2017. "Infrared and Raman Spectroscopy: Principles and Spectral Interpretation." 2nd ed. Amsterdam: Elsevier. Principles of IR/Raman library matching and peak preprocessing.
Structural properties
Loading structural data...
❓ Frequently asked questions (3)
What is Nickel sulfamate?
Nickel sulfamate (CAS 13770-89-3) is a chemical compound with the molecular formula H₄N₂NiO₆S₂ and a molecular weight of 250.87 g/mol.
Helpful?
What is the CAS number of Nickel sulfamate?
The CAS number for Nickel sulfamate is 13770-89-3.
Helpful?
What is the chemical formula of Nickel sulfamate?
The molecular formula of Nickel sulfamate is H₄N₂NiO₆S₂.
Helpful?
➕ Suggest a question
Download structure files
Molecular structure files from the PubChem database (NIH). Compatible with Avogadro, PyMOL, Jmol, and ChemDraw.
Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
g/L ↔ molarity
c (mol/L) = (g/L) / MW
±0.1% (depends on MW precision)
Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
mmol/L ↔ molarity
c (mol/L) = mmol/L × 10⁻³
Exact
Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
Celsius ↔ Kelvin
T(K) = t(°C) + 273.15
±0.01 K (ITS-90 scale)
BIPM (Bureau International des Poids et Mesures) (2019)
Celsius ↔ Fahrenheit
T(°F) = T(°C) × 9/5 + 32
±0.1 °F
Thompson A, Taylor BN (2008)
density-corrected % ↔ molarity
c (mol/L) = (%w/w × ρ × 10) / MW, ρ in g/mL
±0.1% when ρ known to 3 decimals
Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
📚 Bibliography (8 authoritative sources)
Thompson A, Taylor BN (2008). Guide for the Use of the International System of Units (SI). NIST Special Publication 811 · DOI: 10.6028/NIST.SP.811-2008 → Primary SI standard for US scientific usage
Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007). Quantities, Units and Symbols in Physical Chemistry — The IUPAC Green Book. RSC Publishing, 3rd ed. · DOI: 10.1039/9781847557889 · ISBN: 978-0-85404-433-7 → Canonical IUPAC guide for chemistry quantities/units
BIPM (Bureau International des Poids et Mesures) (2019). The International System of Units (SI), 9th edition. BIPM · ↗ → International SI definitions (incl. redefined kilogram 2019)
ISO/IEC (2022). Quantities and units — Part 1: General. International Organization for Standardization — ISO 80000-1:2022 · ↗ → General rules for physical quantities and units
ISO/IEC (2019). Quantities and units — Part 9: Physical chemistry and molecular physics. International Organization for Standardization — ISO 80000-9:2019 · ↗ → Concentration / molality / amount-of-substance conventions
Tiesinga E, Mohr PJ, Newell DB, Taylor BN (2021). CODATA recommended values of the fundamental physical constants: 2018. Rev. Mod. Phys. 93(2):025010 · DOI: 10.1103/RevModPhys.93.025010 → Avogadro, gas constant, molar volume (2019 SI revision)
IUPAC (2019). Compendium of Chemical Terminology — the IUPAC Gold Book (online). IUPAC · DOI: 10.1351/goldbook → Definitions of mass fraction, molality, normality, ppm, activity
Mills IM, Cvitaš T, Homann K, Kallay N, Kuchitsu K (1988). Quantities, Units and Symbols in Physical Chemistry. Blackwell Scientific Publications, 1st ed. · ISBN: 0-632-01773-5 → Historical predecessor of IUPAC Green Book
Data limitations notice. The safety information on this page is for reference only and does not replace a full safety data sheet (SDS). Before using the product, consult the manufacturer's current safety data sheet and the GHS/CLP guidance. The CLP classification applies to the pure bulk substance, not to commercial formulations.
GHS/CLP classification — Regulation (EC) No 1272/2008 + UN GHS Rev. 9 (2021).
H372 — Causes damage to organs through prolonged or repeated exposure
H334 — May cause allergy or asthma symptoms or breathing difficulties if inhaled
H317 — May cause an allergic skin reaction
H400 — Very toxic to aquatic life
H410 — Very toxic to aquatic life with long lasting effects
🛡 Precautionary statements (P)
P203 — Obtain, read and follow all safety instructions before use
✓ Harmonised classification pursuant to Annex VI of the CLP Regulation (EC) 1272/2008 (official, binding classification). Index number: 028-018-00-4.
Reference (Chicago): European Chemicals Agency. "nickel bis(sulfamidate); nickel sulfamate, Index No. 028-018-00-4." In Table 3 of Annex VI to Regulation (EC) No 1272/2008 (CLP Regulation), 23rd Adaptation to Technical Progress (harmonised list as of 2026-07-07). Helsinki: European Chemicals Agency, 2026. https://echa.europa.eu/information-on-chemicals/annex-vi-to-clp.
Translations: CLP Regulation (EC) 1272/2008, Annexes III and IV. Data: PubChem/NLM.
☢️ Toxicological data (IARC + EPA CTX)
🧬 IARC Carcinogen Classification
IARC classification:
⚠️ No individual IARC entry for this CAS
NOTE: substance classified as carcinogenic under ECHA CLP (Carc. 1A, H350i, H341, H360D) — see the CMR section below. The absence of an IARC monograph does not mean the absence of carcinogenicity.
Bartolomeu Halicki PC, Kim JH, Griffin AF et al.. (2025). "Targeting Mycolic Acid Biosynthesis with Cyclic Sulfamates: A New Strategy against Mycobacterium tuberculosis.". ACS infectious diseases. https://doi.org/10.1021/acsinfecdis.5c00419 [DOI]
Sanematsu K, Nagasato Y, Lee Y et al.. (2025). "A single amino acid substitution in TAS1R2 defines species-specific sweet sensitivity to sulfamates in humans and mice.". Food chemistry. https://doi.org/10.1016/j.foodchem.2025.145563 [DOI]
Mustafa EM, Shahin AI, Alrashed AS et al.. (2024). "An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020-2024).". Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400331 [DOI]
Siddiqui R, El-Gamal MI, Sajeev S et al.. (2023). "Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives.". Molecular and biochemical parasitology. https://doi.org/10.1016/j.molbiopara.2023.111582 [DOI]
Hosang L, Löhndorf A, Dohle W et al.. (2023). "2-Methoxyestradiol-3,17-O,O-bis-sulfamate inhibits store-operated Ca(2+) entry in T lymphocytes and prevents experimental autoimmune encephalomyelitis.". Biochimica et biophysica acta. Molecular cell research. https://doi.org/10.1016/j.bbamcr.2023.119485 [DOI]
Sundararaman SA, Odom John AR. (2022). "Adenosine sulfamates: Next generation of antimalarials.". Cell host & microbe. https://doi.org/10.1016/j.chom.2022.07.007 [DOI]
Chang CN, Lin IC, Lin TS et al.. (2022). "The Design, Structure-Activity, and kinetic studies of 3-Benzyl-5-oxa-1,2,3,4-Tetrahydro-2H-chromeno-(3,4-c)pyridin-8-yl sulfamates as Steroid sulfatase inhibitors.". Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2022.106148 [DOI]
Awakawa T, Barra L, Abe I. (2021). "Biosynthesis of sulfonamide and sulfamate antibiotics in actinomycete.". Journal of industrial microbiology & biotechnology. https://doi.org/10.1093/jimb/kuab001 [DOI]
Mazo N, Navo CD, Peregrina JM et al.. (2020). "Selective modification of sulfamidate-containing peptides.". Organic & biomolecular chemistry. https://doi.org/10.1039/d0ob01061h [DOI]
Potter BVL. (2018). "SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects.". Journal of molecular endocrinology. https://doi.org/10.1530/JME-18-0045 [DOI]
Winum JY, Scozzafava A, Montero JL et al.. (2005). "Sulfamates and their therapeutic potential.". Medicinal research reviews. https://doi.org/10.1002/med.20021 [DOI]
(2004). "Nickel (
II
) Sulfamate 13770‐89‐3". Sax's Dangerous Properties of Industrial Materials. https://doi.org/10.1002/0471701343.sdp18463 [DOI]
International Agency for Research on Cancer (IARC). 2024. "IARC Monographs on the Identification of Carcinogenic Hazards to Humans." Lyon: IARC. 🔗
U.S. EPA. 2024. "ECOTOX Knowledgebase." Washington, DC: U.S. Environmental Protection Agency. 🔗
ECHA. 2024. "Chemical Safety Assessment." European Chemicals Agency. 🔗
🚨 Emergency procedure — chemical spillHealth hazard
CAS 13770-89-3GHS:H350iH341H360DH302H372H334H317H400H410💨 Ventilation
🥽 PPE — Personal protective equipment
Goggles:Yes
Suit:lab coat
Respirator:half-mask / full-face respirator per SDS (dust P2/P3)
📦 Small spill (<1L) — absorbent: inert mineral (vermiculite)
⚠️ GENERIC procedure derived from the GHS classification (no curated data for this CAS). Always follow the supplier's current Safety Data Sheet (SDS).
1. Minimize exposure — restrict access by unauthorized persons.
2. Full PPE + respiratory protection; no dust/vapor generation.
3. Sealed, labeled container.
4. Wash the area with water; treat residues and absorbent as hazardous waste.
Additional properties from GHS:
• irritant — avoid skin/eye contact and dust inhalation
• hazardous to the environment — prevent entry into drains, soil and water
🛢️ Large spill (>1L) ⚠️ Hazardous material
1. Evacuate; entry only in full PPE with respiratory protection.
2. Contain; avoid dispersal; follow the site procedure for CMR/STOT substances.
3. Collect mechanically into a labeled UN container; hand over to an authorized company (BDO — national rule, Poland).
4. Report the incident per the OHS procedure; on release to the environment notify the Regional Environmental Inspectorate (WIOŚ) (national rule — Poland).
🩹 First aid
🧴 Skin
1. Remove contaminated clothing.
2. Rinse the skin with plenty of water for ≥15 min.
3. The substance may be absorbed through the skin — monitor symptoms / see a doctor.
👁️ Eyes
1. Rinse with water for ≥15 min, eyelids held open; remove contact lenses.
2. See an ophthalmologist if irritation persists.
🫁 Inhalation
1. Move the casualty to fresh air, comfortable position.
2. If short of breath — oxygen / doctor.
🍽️ Ingestion
1. Rinse the mouth with water; do NOT induce vomiting.
2. Poison Control Center (Poland): +48 42 631 47 24.
🌍 Environment:
Water: High; Soil: Medium; ❌ Do not release into drains; Waste Code: 16 05 06*
📚 Scientific references (Chicago Author-Date) — 8
European Chemicals Agency (ECHA). 2020. Guidance on the Compilation of Safety Data Sheets — Section 6: Accidental Release Measures. ECHA.
[link ↗]
European Parliament and Council. 2008. Regulation (EC) No 1272/2008 (CLP) — Hazard classes and H-statements. Official Journal of the European Union L 353.
[link ↗]
National Institute for Occupational Safety and Health (NIOSH). 2023. Pocket Guide to Chemical Hazards — NIOSH Pocket Guide to Chemical Hazards. CDC.
[link ↗]
U.S. Occupational Safety and Health Administration. 2024. 29 CFR 1910.120 — Hazardous Waste Operations and Emergency Response (HAZWOPER). U.S. Code of Federal Regulations.
[link ↗]
National Fire Protection Association. 2018. NFPA 472: Standard for Competence of Responders to Hazardous Materials/Weapons of Mass Destruction Incidents. NFPA.
[link ↗]
European Parliament and Council. 2012. Directive 2012/18/EU on the Control of Major-Accident Hazards Involving Dangerous Substances (Seveso III). Official Journal of the European Union L 197: 1–37.
[link ↗]
U.S. National Institute for Occupational Safety and Health. 2024. NIOSH Pocket Guide to Chemical Hazards. Centers for Disease Control and Prevention.
[link ↗]
European Chemicals Agency. 2020. Guidance on the Compilation of Safety Data Sheets (SDS), Version 3.1. ECHA.
[link ↗]
Sources: GHS/CLP classification (PubChem/SDS) — generic fallback · ECHA Guidance on SDS (section 6) · NIOSH Pocket Guide.
Indicative data only — in an emergency, always follow the supplier's instructions and local occupational health and safety (OHS) regulations.
ℹ️ Regulatory obligations checklist for CAS 13770-89-3.
Status based on: ADR 2025 (Table A), REACH Annex XVII, CLP Annex VI (harmonised classification), hazard class from the m14-spill DB, SVHC, GIS and the Polish OEL list. Principle: no data = no claim (we do NOT declare "no restrictions" without a basis).
▣SDS (Safety Data Sheet) availablerequired
How to comply: Requirement: current SDS compliant with Reg. 1907/2006 (REACH) Annex II, 16-section format.
Legal basis: Regulation (EC) No 1907/2006 (REACH) Art. 31 + Annex II
▣Compliant CLP label (pictograms + signal word + H/P)required
How to comply: The label must include: GHS pictograms, the signal word (Danger/Warning), hazard (H) and precautionary (P) statements, and manufacturer details. Required since 2010 (substances) and 2015 (mixtures). For this substance a HARMONISED CLASSIFICATION applies (CLP Annex VI) — see below; it takes precedence over self-classification.
Legal basis: Regulation (EC) No 1272/2008 (CLP) Art. 17-33 + Annex VI (harmonised classification)
❓ADR transport (international agreement)to be verified
How to comply: No ADR data in the MOL-GOD dataset for this CAS number. Do NOT assume there are no restrictions — before shipping, verify the transport classification in ADR 2025 (Table A) and in section 14 of the safety data sheet (SDS).
Legal basis: ADR 2025 European Agreement + Polish Act of 19 August 2011 on the Transport of Dangerous Goods National rules — Poland
🔵REACH registration (>1 t/year EU import)conditional
How to comply: Importers/manufacturers ≥1 tonne/year must register the substance with ECHA (technical dossier + Chemical Safety Report if ≥10 t). Check the ECHA Annex VI / registered substances list.
Legal basis: Regulation (EC) No 1907/2006 (REACH) Art. 5-22
▣REACH Annex XVII (use/marketing restrictions)required
How to comply: Substance subject to a REACH Annex XVII restriction (entry 28–30): CMR category 1A/1B — not for supply to the general public (professional users only). Check the conditions for placing on the market/use and the note in SDS section 15.
Legal basis: Regulation (EC) No 1907/2006 (REACH) Annex XVII — restrictions on manufacture, placing on the market and use
⚠️ REACH Annex XVII (entry 28–30): CMR category 1A/1B — not for supply to the general public (professional users only).
European Parliament and Council. 2008. Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (CLP). Official Journal of the European Union L 353/1. CLP Regulation 1272/2008. [link ↗] — Classification, labelling and packaging of substances + mixtures (GHS implementation in the EU)
European Parliament and Council. 2006. Regulation (EC) No 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Official Journal of the European Union L 396/1. REACH Regulation 1907/2006. [link ↗] — REACH — registration, evaluation and authorisation of chemicals; SVHC; SDS Annex II
Ministerstwo Rodziny i Polityki Społecznej Rzeczypospolitej Polskiej. 2024. Rozporządzenie Ministra Rodziny i Polityki Społecznej z dnia 4 września 2024 r. w sprawie najwyższych dopuszczalnych stężeń i natężeń czynników szkodliwych dla zdrowia w środowisku pracy. Dziennik Ustaw RP 2024 poz. 1017. National rules — Poland[link ↗] — NDS and NDSCh for ~600 chemical substances — current Polish occupational exposure limits
United Nations Economic Commission for Europe (UNECE). 2025. European Agreement concerning the International Carriage of Dangerous Goods by Road (ADR), 2025 Edition. United Nations, Geneva. ADR 2025. [link ↗] — International agreement on the road transport of dangerous goods — UN numbers, classes, packaging
📚 Consolidated scientific references — Chicago Author-Date 10 sources
References collected from all Safety Hub tabs. CAS: 13770-89-3 ·
PubChem ↗
Parlament Europejski i Rada UE. 2008. "Regulation (EC) nr 1272/2008 w sprawie klasyfikacji, oznakowania i pakowania substancji (CLP)." Dz.Urz. UE L 353. [↗]
GHS, Regulations
United Nations Economic Commission for Europe (UNECE). 2021. "Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Ninth Revised Edition." United Nations, Geneva. [↗]
GHS
Goldfrank, Lewis R., Robert S. Hoffman, Mary Ann Howland, et al.. 2019. "Goldfrank's Toxicologic Emergencies, 11th ed.." McGraw-Hill Education, New York. ISBN 978-1-25-985961-8.
First aid, Toxicology
National Institute for Occupational Safety and Health (NIOSH). 2023. "NIOSH Pocket Guide to Chemical Hazards (DHHS Publ. 2005-149)." U.S. Department of Health and Human Services / CDC, Cincinnati, OH. [↗]
First aid, PPE, Toxicology
European Committee for Standardization (CEN). 2016. "EN 374-1:2016 — Protective gloves against dangerous chemicals and micro-organisms." CEN, Brussels. [↗]
PPE
UNECE. 2023. "European Agreement Concerning the International Carriage of Dangerous Goods by Road (ADR 2025)." United Nations, Geneva. [↗]
Disposal, Regulations
National Fire Protection Association (NFPA). 2022. "NFPA 400 — Hazardous Materials Code." NFPA, Quincy, MA. [↗]
Storage
Urben, P.G. (ed.). 2017. "Bretherick's Handbook of Reactive Chemical Hazards, 8th ed.." Butterworth-Heinemann / Elsevier, Oxford. [↗]
Storage
Ministerstwo Klimatu i Środowiska RP. 2023. "Baza danych o produktach i opakowaniach oraz o gospodarce odpadami (BDO)." Ministerstwo Klimatu i Środowiska, Warszawa. National rules — Poland[↗]
Disposal
International Agency for Research on Cancer (IARC / WHO). 2024. "IARC Monographs on the Identification of Carcinogenic Hazards to Humans — List of Classifications." WHO, Lyon. [↗]
Toxicology
Tabs with their own references (Emergency, PPE, Storage, Waste) contain additional bibliographic entries within their respective sections.
Paste a series of replicate measurements (CSV, or one number per line). The calculator computes the mean, standard deviation and 95% CI, and detects outliers (Grubbs + Dixon Q).
Separator: comma, space, tab, new line. Minimum 3 measurements.
📐 Statistical formulas
x̄ = Σxᵢ / n — arithmetic mean
s² = Σ(xᵢ - x̄)² / (n-1) — sample variance
s = √s² — standard deviation
RSD% = (s / x̄) × 100% — relative standard deviation
Choose a buffer from the list of 20 popular systems → enter the target pH → get an exact recipe with the masses to weigh out.
Step 1: Choose a buffer system
Step 2: Buffer parameters
Step 3: Your recipe
Step-by-step procedure:
📐 Calculation details (Henderson-Hasselbalch)
📜 Recipe history (last 10)
📅Project Planner — Lab Experiment ManagerNEW
Plan your entire laboratory project: add experiments with reagents, replicates, and duration. You'll get a Gantt chart, a shopping list (with links to the store!), a budget with a 10% margin, and a GHS risk matrix.
💡 Log in to save projects.
Without logging in you can calculate but not save.
🧪 Solubility and solvent compatibility
Molecule
Nickel sulfamate
Formula
H₄N₂NiO₆S₂
logP (XLogP3)
—
Mass (g/mol)
250.87
Polarity
—
⚠️ Ionic / inorganic compound — Hansen parameters (δD/δP/δH) do not apply: dissolution is governed by crystal-lattice energy and ion solvation, not molecular cohesion. The HSP block and Hansen sphere are omitted. HSP-dependent columns (Compat./Ra/Visual) are marked "n/a" — base solvent selection on experimental data.
Solvent compatibility table not available for this substance.
The Hansen parameters fall outside the range of the method, so the distance Ra cannot be calculated, and the database holds no solubility measurement to put in its place. Rather than eleven ratings with nothing behind them, we show none. Base the solvent choice on the safety data sheet and on experimental data.
Solubility theory (applied in compatibility prediction):
Yalkowsky, Samuel H., and Shri C. Valvani. 1980. "Solubility and Partitioning I: Solubility of Nonelectrolytes in Water." Journal of Pharmaceutical Sciences 69 (8): 912–922. https://doi.org/10.1002/jps.2600690814 — General Solubility Equation (GSE): logS = 0.5 − logP − 0.01(MP−25).
Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. CRC Press. https://doi.org/10.1201/9781420006834 — HSP triplet (dD, dP, dH) + Ra formula.
Stefanis, E., and C. Panayiotou. 2008. "Prediction of Hansen Solubility Parameters with a New Group-Contribution Method." Int J Thermophys 29: 568–585. https://doi.org/10.1007/s10765-008-0415-z
Reichardt, Christian, and Thomas Welton. 2011. Solvents and Solvent Effects in Organic Chemistry. 4th ed. Wiley-VCH. https://doi.org/10.1002/9783527632220 — E_T(30) polarity scale, solvatochromism.
Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. Introduction to Modern Liquid Chromatography. 3rd ed. Wiley. https://doi.org/10.1002/9780470508183 — Eluotropic series, polarity index.
Van Krevelen, D. W., and K. Te Nijenhuis. 2009. Properties of Polymers. 4th ed. Elsevier. https://doi.org/10.1016/B978-0-08-054819-7.X0001-5 — Hoftyzer–Van Krevelen group contribution for dD/dP/dH from SMILES.
Marcus, Yizhak. 1998. The Properties of Solvents. Wiley Series in Solution Chemistry, Vol. 4. ISBN 9780471983699 — Complete tabular set of 250+ solvents (ε, μ, donicity, acceptor numbers).
PubChem Compound Database — CAS 13770-89-3 lookup ↗ — logP (XLogP3), water solubility experimental + predicted.
Full bibliography in the REFERENCES accordion (at the bottom of the page) — Chicago Manual of Style 17th ed., Author-Date.
🧮 Solubility calculator
Solubility:—
logS:—
Method:—
⚠️ —
Solubility vs temperature
🌐 Hansen Solubility Sphere (3D)
⚠️ Hansen parameters do not apply to ionic compounds / inorganic salts.
Salt dissolution is governed by crystal lattice energy and ion solvation, not by the molecular cohesion described by δD/δP/δH. The HSP triplet and the Hansen sphere have been omitted — for this substance they would be an estimate without physical basis (rather than a literature value). Base solvent selection on experimental data: solubility in water and water-organic systems.
Ra < R₀ = good miscibility · Ra < 1,5×R₀ = borderline · above = poor (R₀ — radius of the Hansen sphere of this molecule) Target molecule: δD=n/d,
δP=n/d,
δH=n/d— ionic compound: Hansen parameters do not apply
📊 Automatically extracted topics from the abstracts of 11 publications for CAS 13770-89-3.
Algorithm: TF-IDF (Salton & Buckley 1988) — term frequency × inverse document frequency.
bath 6
plating 6
current 3
composite 3
electrodeposition under 2
properties 2
prepared 2
films 2
electrodeposited 2
influence 2
🔍 Ranking details (TF-IDF)
Tag
TF
DF
IDF
Score
bath
6
4
1.875
11.253
plating
6
6
1.539
9.234
current
3
2
2.386
7.159
composite
3
2
2.386
7.159
electrodeposition under
2
2
2.386
6.682
properties
2
2
2.386
4.773
prepared
2
2
2.386
4.773
films
2
2
2.386
4.773
electrodeposited
2
2
2.386
4.773
influence
2
2
2.386
4.773
🔗 Citation network11 seed papers
📊 Citation graph for CAS 13770-89-3.
Each node = a research paper; an A→B edge = paper A cites B. Data from OpenAlex (Priem 2022).
⚡ Fetch network data
Network built on-demand from the OpenAlex API (24h cache).
Why this page can be checked
Identity
CAS, EC and molecular formula, resolved across the identifier systems a buyer uses. The count of systems resolved is shown, so you can see how well characterised this substance is rather than assuming.
Data
Every physicochemical value carries the source it came from and the date that source was read. Open any of them.
Classification
Read against the harmonised entry where one exists, with the index number stated. Self-classification is shown separately and labelled.
Regulatory
Inventory, restriction, authorisation and candidate-list status, each stated individually. Where a status is not established, this page says so — it never says no restrictions apply.
Documentation
Which documents exist, at what review level, in which languages, and when each was issued.
Supplier
Who is selling this, and what they have published about themselves.
Nothing on this page is a certification. It is a record you can audit.
Two guarantees, both with their limits stated
The Gap Report Guarantee
If the available evidence cannot support a defensible document for your CAS number and product specification, we will not invent the missing values. You receive a documented gap report and choose: a refund, store credit, or the report on its own.
A visible gap is worth more than a plausible number, because the plausible number is the one that fails when somebody checks it.
The Re-issue Promise
If a signed card is rejected by an authority or by a customer’s compliance officer on one of the points we checked and reported as passed, we re-issue it corrected at no charge and credit the original fee.
This covers the checks we performed and named. It does not cover registration status, tonnage, or your role in the supply chain — those are not ours to hold, and a guarantee that pretended otherwise would be worth nothing.
A safety data sheet for nickel bis(sulfamidate), CAS 13770-89-3, in the sixteen-section structure required across the European Union. The deliverable is the document itself.
nickel bis(sulfamidate) (CAS 13770-89-3) at a glance
Substance – nickel bis(sulfamidate)
CAS number – 13770-89-3
EC number – 237-396-1
CLP Annex VI index number – 028-018-00-4
Also known as – nickel sulfamate
Hazard statements – H350i; H341 (suspected of causing genetic defects); H360D (may damage the unborn child); H302 (harmful if swallowed); H372 (causes damage to organs through prolonged or repeated exposure); H334 (may cause allergy or asthma symptoms if inhaled)
Hazard classes – Carc. 1A, Muta. 2, Repr. 1B, Acute Tox. 4, STOT RE 1, Resp. Sens. 1
Label pictograms – GHS07, GHS08, GHS09
Signal word – Danger
Concentration limits / M-factor / ATE – oral: ATE = 853.0 mg/kg bw (anhydrate);oral: ATE = 1098.0 mg/kg bw (tetrahydrate);STOT RE 1;H372: C ≥ 1.0%;STOT RE 2;H373: 0.1% ≤ C < 1.0%;Skin Sens. 1;H317: C ≥ 0.01%;M = 1
Entry current as of – ATP14
CMR classification – yes, classified as carcinogenic, mutagenic or toxic for reproduction
Documentation issued – safety data sheet in REACH Annex II structure; working draft or signed card
What is supplied – a document. MolGod.org does not sell, supply or ship chemical substances.
Who is responsible for REACH compliance for nickel bis(sulfamidate)?
Anyone importing nickel bis(sulfamidate) into the European Union is responsible for providing the required documentation, and this obligation does not revert to previous entities in the supply chain through contractual means. Section 1 mandates the designation of a contactable entity within the Union; a foreign address is considered invalid for this purpose and is one of the first elements verified by inspectors due to its straightforward confirmation.
Purity, certificates and what the sheet does not say
A laboratory receiving nickel bis(sulfamidate) from its supplier holds two documents that must agree with each other: the safety data sheet for the substance and the certificate for the batch in hand. Where identity or supplier details diverge between them, both become questionable. MolGod prepares and audits those documents; the material itself comes from your supplier.
Which GHS pictograms apply to nickel bis(sulfamidate)?
The label for nickel bis(sulfamidate) carries GHS07 (exclamation mark), GHS08 (health hazard), GHS09 (environment), with the signal word Danger. These are not chosen by the supplier: CLP Annex VI states them for CAS 13770-89-3, and the precedence rules in Annex I decide which pictogram is dropped when two would say the same thing. A label showing a different set from the register is wrong even if every hazard statement on it is correct.
What happens if a consignment of nickel bis(sulfamidate) is refused?
When a consignment of nickel bis(sulfamidate) is held, the cost is rarely the document itself. It is the storage, the demurrage and the customer waiting. That arithmetic is why the sheet is worth checking before dispatch rather than after a call from the border.
What is the CLP classification of nickel bis(sulfamidate)?
The harmonised classification for CAS 13770-89-3 carries 9 hazard statements: H350i, H341, H360D, H302, H372, H334, H317, H400, H410. In plain terms this means H350i; suspected of causing genetic defects; may damage the unborn child; harmful if swallowed. A harmonised entry is binding across the Union — an importer may not soften it, and a self-classification that diverges from it will not survive an enforcement check.
Storage and handling in the document
The store manager responsible for managing material with CAS number 13770-89-3 must review Section 7 first to determine its compatibility with adjacent materials, required atmosphere conditions, and any segregation rules arising from its classification. The necessary information regarding these aspects must be explicitly stated in the documentation provided, rather than relying on supplier email correspondence.
What is the EC number for nickel bis(sulfamidate)?
Alongside CAS 13770-89-3, this substance carries EC number 237-396-1 and Annex VI index 028-018-00-4. European documentation is built around the EC number as often as around the CAS: registration dossiers, the candidate list and customs systems key on it. A safety data sheet quoting only one of the two forces every downstream reader to look up the other.
What concentration limits apply to nickel bis(sulfamidate)?
The harmonised entry for nickel bis(sulfamidate) carries specific concentration limits: H372: C ≥ 1 %; H373: 0,1 % ≤ C < 1 %; H317: C ≥ 0,01 %. These override the generic cut-off values, so a mixture containing nickel bis(sulfamidate) is classified against these figures and not against the default thresholds. M-factor on record: 1. The M-factor multiplies the contribution of this substance in the aquatic hazard calculation for a mixture, which is where it is most often overlooked. Acute toxicity estimates stated in the register: oral: ATE = 853 mg/kg; oral: ATE = 1098 mg/kg.
Is nickel bis(sulfamidate) classified as a CMR substance?
CAS 13770-89-3 is classified as a CMR substance (H350i, H360D). That status changes the obligations attached to every shipment: workplace exposure documentation, restrictions on supply to the general public, and substitution pressure from downstream users who must justify continued use. A safety data sheet for a CMR substance is read more closely than any other, because the classification itself invites scrutiny.
What must the label for nickel bis(sulfamidate) contain?
The supply label for nickel bis(sulfamidate) is generated from the same classification that drives the safety data sheet: pictograms selected by precedence, one signal word derived from the highest hazard class present, and the hazard statements H350i, H341, H360D… reproduced in full. Where the container is too small to carry the complete set at a legible size, there are lawful ways to handle it and unlawful ones that look identical to a non-specialist.
What Annex VI notes and concentration limits apply to nickel bis(sulfamidate)?
The register also records oral: ATE = 853.0 mg/kg bw (anhydrate);oral: ATE = 1098.0 mg/kg bw (tetrahydrate);STOT RE 1;H372: C ≥ 1.0%;STOT RE 2;H373: 0.1% ≤ C < 1.0%;Skin Sens. 1;H317: C ≥ 0.01%;M = 1 for this entry. Specific concentration limits, M-factors and acute toxicity estimates override the generic cut-off values, so a mixture calculation that ignores them will classify the mixture wrongly in both directions.
Where is regulatory status recorded for nickel bis(sulfamidate)?
The regulatory status of nickel bis(sulfamidate) evolves separately from its hazard classification. A substance may maintain consistent hazard characteristics over extended periods while gaining additional obligations under Section 15, leading to this section becoming outdated more rapidly than Section 2.
Identifiers that must agree
The CAS 13770-89-3 number and index number 028-018-00-4 are not interchangeable or decorative elements; they serve distinct purposes. The index number connects to the harmonised classification system, whereas the CAS number links to chemical literature. A document containing one without the other requires readers to independently reconstruct this relationship, which may lead to errors during reconstruction.
How is nickel bis(sulfamidate) classified for road, sea and air transport?
The transport classification for nickel bis(sulfamidate) falls under section 14 and varies depending on the mode of transport: ADR for road, IMDG for sea, and IATA for air. A document that prints all three classifications without specifying which one applies places the responsibility on the shipper to select the correct one, and it is the shipper who faces penalties for making an incorrect choice.
Sensitisation and declaration thresholds
Sensitisation (H334, H317) carries consequences beyond the label: a threshold for declaring the substance in mixtures far below the general cut-off, and — where the entry is on the candidate list — an obligation to inform recipients. Importers frequently discover this at the point where a customer asks for a declaration they had not prepared.
Questions about documentation for nickel bis(sulfamidate)
Can I check whether my existing sheet is still valid?
Yes. A section-by-section reading against Annex II and the current harmonised entry establishes that in one pass, and a sheet that passes is reported as passing.
Do I need a safety data sheet to import nickel bis(sulfamidate) into the EU?
Yes. A sheet compiled to Annex II of REACH must exist before the first consignment moves, and it must be held by the entity placing the substance on the Union market.
What is the CAS number of nickel bis(sulfamidate)?
CAS 13770-89-3. In CLP Annex VI the same substance carries index number 028-018-00-4, and both identifiers should appear in the documentation.
Is nickel bis(sulfamidate) a CMR substance?
Yes. The harmonised classification places it among substances classified as carcinogenic, mutagenic or toxic for reproduction, which changes workplace documentation and supply restrictions.
MolGod.org issues documentation and does not sell, supply or ship chemical substances. CAS 13770-89-3 identifies the subject of this document.
Which version do you need?
📄
SDS Working Draft
€49.99
Delivered automatically after payment, by e-mail
Full 16-section REACH Annex II structure
Classification against ECHA CLP Annex VI
Public-source data with references
Unresolved gaps flagged, never filled by guesswork
For internal drafting and supplier review. Unsigned; supplier-specific fields may need completing.
Best for
Seeing what the document will contain before you commit
Comparing what a supplier sent you against the register
Finding the gaps in a sheet you already hold
Preparing an internal file before an export decision
Substances you handle but do not yet sell
Recommended when the document leaves your company✍
Expert-Reviewed SDS
€249.99
Everything in the Working Draft
Reviewed by a competent person under Annex II, section by section
Adapted to your company, product grade and identified use
Destination market and language checked
Transport section reviewed for the mode you request
Five rounds of corrections applied to your instructions
Within 72 hours of receiving complete input.
Best for
Any document that leaves your company
A customer or distributor who asked for the sheet
Paperwork travelling with an export shipment
A sheet an inspector or authority may read
Replacing a sheet a customer has already rejected
If you are unsure, read down the left column and stop at the first line that describes your situation.
What the document is for
Working Draft €49.99
Expert-Reviewed €249.99
Internal drafting and review
Yes
Yes
Checking a sheet a supplier sent you
Yes
Yes
Sent to your customer
Not written for this
Yes
Travels with an export shipment
Not written for this
Yes
Read by an inspector or authority
Not written for this
Yes
Adapted to your company, grade and identified use
No
Yes
Signed and dated by the reviewer
No
Yes
When you get it
Immediately after payment
Within 72 hours of complete input
Nothing stops you sending a draft to anyone. "Not written for this" means exactly that: it carries no signature and no fields adapted to your company, so it will not answer the questions the recipient is about to ask.
What the signature means
Who prepares the document
The document is generated by the MolGod engine from ECHA CLP Annex VI and the cited public sources, then read section by section by a qualified scientific reviewer with a degree in chemistry or a related scientific field.
What the review covers
The sheet is read section by section against the REACH Annex II structure. GHS classification and transport entries are checked against the sources cited in the document, and the sheet is adapted to the company, product grade and identified use you provide.
What is NOT verified
We do not test your material and we cannot confirm what is physically in your container: composition, concentration, impurities or manufacturing route. Those come from you and are reproduced as supplied.
What the signature is — and is not
The signature records that a qualified scientific reviewer read the document. It is not a government approval, not an ECHA approval, and not a legal certification — no such certification exists for safety data sheets in the EU. A signature does not by itself make a document legally valid or make your business compliant.
What you receive
A PDF in the 16-section REACH Annex II structure, signed and dated, with version information and a list of anything we could not establish. Five rounds of corrections are included.
Delivery
Within 72 hours of receiving complete input from you. The clock pauses whenever we are waiting on an answer.
Refunds
Full refund before review begins. If the evidence is insufficient, you choose a refund, store credit or a gap report. See the refund policy.
No fabricated-data guarantee.
If the available evidence is insufficient to support a defensible document for this CAS number and your product specification, we will not invent the missing values. You may choose a refund, store credit or a documented gap report.
The supplier placing the substance or mixture on the market remains responsible for ensuring that the final safety data sheet matches the material, its identified uses and their legal role in the supply chain.
📄 Certificates of Analysis (CoA)CAS 13770-89-3none
No certificates for this product in the database.
📚 Scientific references (Chicago Author-Date) — click to expand
Batch management and laboratory certification standards — 13 independent sources (ICH Q1/Q3/Q6/Q7/Q10 + ISO 17025 + WHO TRS + 21 CFR 211 + EMA + USP + Ph.Eur. + PIC/S + IPEC-PQG).
International Council for Harmonisation (ICH). 2000. "Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients." ICH Expert Working Group. [link ↗] — GMP for APIs — adopted by EMA, FDA, MHLW
International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories." ISO. [link ↗] — Lab accreditation standard underpinning every CoA
World Health Organization. 2010. "WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles (WHO Technical Report Series No. 957, Annex 3)." WHO Press. [link ↗] — WHO TRS No. 957 — global reference for GMP
International Council for Harmonisation (ICH). 2003. "ICH Q1A(R2): Stability Testing of New Drug Substances and Products." International Council for Harmonisation. [link ↗] — Source for batch shelf-life and retest dating
International Council for Harmonisation (ICH). 2006. "ICH Q3A(R2): Impurities in New Drug Substances." ICH. [link ↗]
International Council for Harmonisation (ICH). 1999. "ICH Q6A: Specifications for New Drug Substances and Products." ICH. [link ↗] — CoA acceptance-criteria specification standard
International Council for Harmonisation (ICH). 2008. "ICH Q10: Pharmaceutical Quality System." ICH. [link ↗]
U.S. Food and Drug Administration. 2024. "21 CFR Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals." US Code of Federal Regulations. [link ↗] — US legal mandate (Subpart J — Records and Reports)
European Medicines Agency. 2014. "Guideline on Process Validation for Finished Products — Information and Data to Be Provided EMA/CHMP/CVMP/QWP/BWP/70278/2012." European Medicines Agency. [link ↗]
United States Pharmacopeial Convention. 2024. "United States Pharmacopeia and National Formulary, USP 47-NF 42." USP. [link ↗]
European Pharmacopoeia Commission. 2024. "European Pharmacopoeia 11th Edition." Council of Europe — EDQM. [link ↗]
Pharmaceutical Inspection Co-operation Scheme (PIC/S). 2021. "Guide to Good Manufacturing Practice for Medicinal Products PE 009-15." PIC/S Secretariat, Geneva. [link ↗] — Cross-recognized GMP for 54 inspectorates worldwide
International Pharmaceutical Excipients Council (IPEC) and Pharmaceutical Quality Group (PQG). 2017. "Joint IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients." IPEC-Americas. [link ↗] — Excipient-grade CoA standard for non-API ingredients
📜 Patents (public metadata)
no data
No public patent metadata was found for this substance in Crossref / OpenAlex at this time. Data will be updated automatically after the next cache refresh (24h).
📚 References (Chicago Author-Date) — click to expand
Bartolomeu Halicki PC, Kim JH, Griffin AF et al.. (2025). "Targeting Mycolic Acid Biosynthesis with Cyclic Sulfamates: A New Strategy against Mycobacterium tuberculosis.". ACS infectious diseases. https://doi.org/10.1021/acsinfecdis.5c00419
Sanematsu K, Nagasato Y, Lee Y et al.. (2025). "A single amino acid substitution in TAS1R2 defines species-specific sweet sensitivity to sulfamates in humans and mice.". Food chemistry. https://doi.org/10.1016/j.foodchem.2025.145563
Mustafa EM, Shahin AI, Alrashed AS et al.. (2024). "An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020-2024).". Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400331
Siddiqui R, El-Gamal MI, Sajeev S et al.. (2023). "Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives.". Molecular and biochemical parasitology. https://doi.org/10.1016/j.molbiopara.2023.111582
Hosang L, Löhndorf A, Dohle W et al.. (2023). "2-Methoxyestradiol-3,17-O,O-bis-sulfamate inhibits store-operated Ca(2+) entry in T lymphocytes and prevents experimental autoimmune encephalomyelitis.". Biochimica et biophysica acta. Molecular cell research. https://doi.org/10.1016/j.bbamcr.2023.119485
Sundararaman SA, Odom John AR. (2022). "Adenosine sulfamates: Next generation of antimalarials.". Cell host & microbe. https://doi.org/10.1016/j.chom.2022.07.007
Chang CN, Lin IC, Lin TS et al.. (2022). "The Design, Structure-Activity, and kinetic studies of 3-Benzyl-5-oxa-1,2,3,4-Tetrahydro-2H-chromeno-(3,4-c)pyridin-8-yl sulfamates as Steroid sulfatase inhibitors.". Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2022.106148
Awakawa T, Barra L, Abe I. (2021). "Biosynthesis of sulfonamide and sulfamate antibiotics in actinomycete.". Journal of industrial microbiology & biotechnology. https://doi.org/10.1093/jimb/kuab001
Mazo N, Navo CD, Peregrina JM et al.. (2020). "Selective modification of sulfamidate-containing peptides.". Organic & biomolecular chemistry. https://doi.org/10.1039/d0ob01061h
Potter BVL. (2018). "SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects.". Journal of molecular endocrinology. https://doi.org/10.1530/JME-18-0045
Winum JY, Scozzafava A, Montero JL et al.. (2005). "Sulfamates and their therapeutic potential.". Medicinal research reviews. https://doi.org/10.1002/med.20021
(2004). "Nickel (
II
) Sulfamate 13770‐89‐3". Sax's Dangerous Properties of Industrial Materials. https://doi.org/10.1002/0471701343.sdp18463
World Intellectual Property Organization. 2024. "Patent Cooperation Treaty (PCT)." https://www.wipo.int/pct/.
U.S. Patent and Trademark Office. 2024. "USPTO Patent Public Search." https://ppubs.uspto.gov/.
European Patent Office. 2024. "Espacenet Patent Search." https://worldwide.espacenet.com/.
Newman, David J., and Gordon M. Cragg. 2020. "Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019." Journal of Natural Products 83 (3): 770-803.
Davies, Mark, Michał Nowotka, George Papadatos, et al. 2015. "ChEMBL Web Services: Streamlining Access to Drug Discovery Data and Utilities." Nucleic Acids Research 43 (W1): W612-W620.
Bickerton, G. Richard, Gaia V. Paolini, Jérémy Besnard, Sorel Muresan, and Andrew L. Hopkins. 2012. "Quantifying the Chemical Beauty of Drugs." Nature Chemistry 4 (2): 90-98.
Meanwell, Nicholas A. 2011. "Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design." Journal of Medicinal Chemistry 54 (8): 2529-2591.
Ertl, Peter, and Ansgar Schuffenhauer. 2009. "Estimation of Synthetic Accessibility Score of Drug-Like Molecules Based on Molecular Complexity and Fragment Contributions." Journal of Cheminformatics 1: 8.
Hopkins, Andrew L., and Colin R. Groom. 2002. "The Druggable Genome." Nature Reviews Drug Discovery 1 (9): 727-730.
Allison, John R., and Mark A. Lemley. 1998. "Empirical Evidence on the Validity of Litigated Patents." AIPLA Quarterly Journal 26 (3): 185-275.
Patani, George A., and Edmond J. LaVoie. 1996. "Bioisosterism: A Rational Approach in Drug Design." Chemical Reviews 96 (8): 3147-3176.
Lerner, Josh. 1994. "The Importance of Patent Scope: An Empirical Analysis." RAND Journal of Economics 25 (2): 319-333.
Have a blog, forum or scientific service? Embed the interactive 3D molecule on your website — every reader will see it, with a link below to the safety data sheet for that substance.
🔗 HTML iframe code (easiest — works everywhere)
Copy and paste into your site's HTML editor:
Adjust width and height to your layout.
⚙ WordPress Shortcode (for other shops with MOL-GOD)
🌐 Direct link (for emails, chats, LinkedIn, Twitter)
When you share the link, Facebook/LinkedIn/Discord will automatically fetch the image preview:
📋 License: The embed keeps a backlink to MolGod (required — the shop is the data source). Chemical data comes from PubChem (CC0 — public domain). The embed is FREE for educational, commercial and hobby use.
📚 REFERENCES (Aggregate bibliography, Chicago Author-Date) 78 items
All scientific sources cited in the accordions above for CAS 13770-89-3. Format: Chicago Manual of Style 17th ed., Author-Date system.
AIST. n.d. Spectral Database for Organic Compounds (SDBS): CAS 13770-89-3. Tsukuba, Japan: National Institute of Advanced Industrial Science and Technology. https://sdbs.db.aist.go.jp/.
Linstrom, Peter J., and William G. Mallard, eds. n.d. NIST Chemistry WebBook: NIST Standard Reference Database Number 69. Gaithersburg, MD: National Institute of Standards and Technology. https://doi.org/10.18434/T4D303.
PubChem. n.d. PubChem Compound Summary: CAS 13770-89-3. Bethesda, MD: National Center for Biotechnology Information (NCBI), National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/#query=13770-89-3.
European Chemicals Agency (ECHA). 2024. "Annex VI to Regulation (EC) No 1272/2008 (CLP) — Harmonised Classification and Labelling." ECHA, Helsinki / Official Journal of the European Union. https://echa.europa.eu/regulations/clp/clp-classification.
National Institute for Occupational Safety and Health (NIOSH). 2017. "Recommendations for Chemical Protective Clothing: A Companion to the NIOSH Pocket Guide." U.S. Department of Health & Human Services / CDC. https://www.cdc.gov/niosh/ncpc/default.html.
Connors, Kenneth A., Gordon L. Amidon, and Valentino J. Stella. 1986. Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists, 2nd ed.. New York: Wiley. https://doi.org/10.1002/0471734683.
Rumble, John R., ed. 2019. CRC Handbook of Chemistry and Physics: 100th Edition. Boca Raton, FL: CRC Press. https://hbcp.chemnetbase.com/.
Stefanis, Emmanuel, and Costas Panayiotou. 2008. "Prediction of Hansen Solubility Parameters with a New Group-Contribution Method." International Journal of Thermophysics 29: 568-585. https://doi.org/10.1007/s10765-008-0415-z.
Stoll, Vincent S., and John S. Blanchard. 1990. "Buffers: Principles and Practice: In Methods in Enzymology, vol. 182." San Diego: Academic Press. https://doi.org/10.1016/0076-6879(90)82008-P.
European Parliament. 2008. "Regulation (EC) No 1272/2008 on Classification, Labelling and Packaging of Substances and Mixtures (CLP)." Official Journal of the European Union L 353: 1–1355.
United Nations. 2021. Globally Harmonized System of Classification and Labelling of Chemicals (GHS). 9th revised ed. ST/SG/AC.10/30/Rev.9. New York and Geneva: United Nations. https://unece.org/ghs-rev9-2021.
United States Pharmacopeial Convention. 2024. "USP <621> Chromatography." In United States Pharmacopeia and National Formulary, USP 47-NF 42. Rockville, MD: USP. https://www.uspnf.com/.
International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories." Geneva: ISO. https://www.iso.org/standard/66912.html.
Kolthoff, Izaak Maurits, and Philip J. Elving, eds. 1978. Treatise on Analytical Chemistry, Part I: Theory and Practice. 2nd ed. New York: Wiley-Interscience.
Skoog, Douglas A., F. James Holler, and Stanley R. Crouch. 2018. Principles of Instrumental Analysis. 7th ed. Boston: Cengage Learning.
Christian, Gary D., Purnendu K. Dasgupta, and Kevin A. Schug. 2014. Analytical Chemistry. 7th ed. Hoboken, NJ: Wiley.
International Organization for Standardization. 1994. "ISO 5725-2:1994 Accuracy (Trueness and Precision) of Measurement Methods and Results — Part 2: Basic Method for the Determination of Repeatability and Reproducibility of a Standard Measurement Method." Geneva: ISO. https://www.iso.org/standard/11834.html.
Heckert, N. A., and J. J. Filliben. 2003. "NIST/SEMATECH e-Handbook of Statistical Methods." NIST Handbook 151. Gaithersburg, MD: National Institute of Standards and Technology. https://www.itl.nist.gov/div898/handbook/.
Grubbs, Frank E. 1950. "Sample Criteria for Testing Outlying Observations." Annals of Mathematical Statistics 21 (1): 27–58.
Dixon, Wilfrid J. 1950. "Analysis of Extreme Values." Annals of Mathematical Statistics 21 (4): 488–506.
Snedecor, George W., and William G. Cochran. 1989. Statistical Methods. 8th ed. Ames, IA: Iowa State University Press.
Student [William Sealy Gosset]. 1908. "The Probable Error of a Mean." Biometrika 6 (1): 1–25.
International Organization for Standardization. 2005. "ISO 3534-1:2006 Statistics — Vocabulary and Symbols — Part 1: General Statistical Terms and Terms Used in Probability." Geneva: ISO. https://www.iso.org/standard/40145.html.
Thompson, Michael, Stephen L. R. Ellison, and Roger Wood. 2002. "Harmonized Guidelines for Single-Laboratory Validation of Methods of Analysis." Pure and Applied Chemistry 74 (5): 835–855.
United Nations Economic Commission for Europe. 2024. European Agreement Concerning the International Carriage of Dangerous Goods by Road (ADR), Applicable as from 1 January 2025 (ECE/TRANS/352). Geneva: UNECE. https://unece.org/transport/dangerous-goods/adr-2025-edition.
Ministerstwo Klimatu i Środowiska Rzeczypospolitej Polskiej. 2020. "Rozporządzenie Ministra Klimatu z dnia 2 stycznia 2020 r. w sprawie katalogu odpadów." Dziennik Ustaw RP 2020 poz. 10. https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20200000010. National rules — Poland
Główny Inspektorat Ochrony Środowiska (GIOŚ). 2024. "Baza Danych O Odpadach (BDO) — System rejestracji firm utylizacyjnych." Ministerstwo Klimatu i Środowiska. https://bdo.mos.gov.pl/. National rules — Poland
International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories." ISO. https://www.iso.org/standard/66912.html.
World Health Organization. 2010. "WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles (WHO Technical Report Series No. 957, Annex 3)." WHO Press. https://www.who.int/publications/m/item/trs957-annex3.
Pharmaceutical Inspection Co-operation Scheme (PIC/S). 2021. "Guide to Good Manufacturing Practice for Medicinal Products PE 009-15." PIC/S Secretariat, Geneva. https://picscheme.org/en/publications.
